#BEGIN_DRUGCARD DB03808

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C20H26N4O2

# Chemical_IUPAC_Name:
4-{[6-(4-carbamimidoylphenoxy)hexyl]oxy}benzene-1-carboximidamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Anti-Infective Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
4,4'[1,6-Hexanediylbis(Oxy)]Bisbenzenecarboximidamide

# HET_ID:
DID

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H26N4O2/c21-19(22)15-5-9-17(10-6-15)25-13-3-1-2-4-14-26-18-11-7-16(8-12-18)20(23)24/h5-12H,1-4,13-14H2,(H3,21,22)(H3,23,24)

# InChI_Key:
InChIKey=OQLKNTOKMBVBKV-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3808

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
354.446

# Molecular_Weight_Mono:
354.205576096

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1RPW

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.77

# Predicted_LogS:
-4.4

# Predicted_Water_Solubility:
1.42e-02 g/l

# Primary_Accession_No:
DB03808

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
65130

# PubChem_Substance_ID:
46505102

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01203

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:38 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AJ400722

# Drug_Target_1_GenBank_ID_Protein:
8574416

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
qacR

# Drug_Target_1_Gene_Sequence:
>567 bp
TTATTTACTAAGTCCATTTAAAAAAATTTGAGAGAACTTGTTCATAAGTTTAATTCTTTC
ATTAATATTTTGTTCATGTGTAAAGGTAACAATTCCATTAACAGCGTTTGCTGCTATTTT
ACTAACAGCATTAACATCATTAATACACCATTCGCCATTTAAATTACCCTCCTTAAAAAT
TACATGATAAGCATCTATATATTTGTTTTCTAATTTATTCATTTTTTCATTAATGCTATT
AGTTTTATAATATTCAGTGTAAAATTCAATTATTGCGTTTTGAAGTGGATAATAGTATTC
GGTTGTTAAAGATAGTTCATTATATAAATAAAATTTTTCTCTATTAGTTTTACATTTGAT
TTGTTCCTTTTTCCACTGTTCTTGCCATTTAGATTCTTCTATATTTAAAATTTCTAAAAA
TAGATTTTCTTTTGTTTTAAAGTGATAATAAAGATTCCCTTTACTACTTTCTGATAATTT
AACAATTTCTCCAGTAGTAGTGGCATTATATCCATTTTTTATAAATAATTCCTTTGCGAC
ACCTAGTATTTTATCTTTCAAGTTCAT

# Drug_Target_1_General_Function:
Transcription

# Drug_Target_1_General_References:
12384372	Anthonisen IL, Sunde M, Steinum TM, Sidhu MS, Sorum H: Organization of the antiseptic resistance gene qacA and Tn552-related beta-lactamase genes in multidrug- resistant Staphylococcus haemolyticus strains of animal and human origins. Antimicrob Agents Chemother. 2002 Nov;46(11):3606-12.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2331

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
22175

# Drug_Target_1_Name:
HTH-type transcriptional regulator qacR

# Drug_Target_1_Number_of_Residues:
188

# Drug_Target_1_PDB_ID:
1QVU

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00440	TetR_N
PF08360	TetR_C_5

# Drug_Target_1_Protein_Sequence:
>HTH-type transcriptional regulator qacR
MNLKDKILGVAKELFIKNGYNATTTGEIVKLSESSKGNLYYHFKTKENLFLEILNIEESK
WQEQWKKEQIKCKTNREKFYLYNELSLTTEYYYPLQNAIIEFYTEYYKTNSINEKMNKLE
NKYIDAYHVIFKEGNLNGEWCINDVNAVSKIAANAVNGIVTFTHEQNINERIKLMNKFSQ
IFLNGLSK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Transcriptional repressor of qacA. Binds to IR1, an unusually long 28 bp operator, which is located downstream from the qacA promoter and overlaps its transcription start site. QacR is induced from its IR1 site by binding to one of many structurally dissimilar cationic lipophilic compounds, which are also substrates of qacA

# Drug_Target_1_SwissProt_ID:
P0A0N5

# Drug_Target_1_SwissProt_Name:
QACR_STAHA

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
8.55

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X56628

# Drug_Target_2_GenBank_ID_Protein:
46660

# Drug_Target_2_GeneCard_ID:
qacR

# Drug_Target_2_Gene_Name:
qacR

# Drug_Target_2_Gene_Sequence:
>1545 bp
CTGATTTCATTTTTTACAAAAACTACTGATATGATGACATCAAAAAAAAGATGGACTGCA
CTAGTAGTATTAGCTGTTAGTTTGTTTGTTGTTACAATGGATATGACAATATTAATTATG
GCTTTACCGGAATTAGTAAGAGAGTTAGAGCCTTCTGGTACCCAACAGTTATGGATAGTT
GATATATACTCTCTTGTTTTAGCTGGCTTTATAATTCCATTGAGTGCCTTTGCTGATAAA
TGGGGAAGAAAAAAAGCATTATTAACTGGATTTGCTTTATTTGGCCTCGTTTCATTAGCT
ATATTTTTCGCAGAAAGTGCAGAGTTCGTAATAGCTATTCGATTTTTACTTGGTATTGCA
GGTGCTTTAATAATGCCAACTACCCTTTCAATGATAAGAGTAATTTTTGAAAACCCTAAA
GAAAGGGCCACTGCATTAGCTGTATGGTCAATCGCTTCATCGATAGGTGCTGTTTTTGGA
CCAATTATCGGAGGAGCTTTACTTGAGCAATTTTCATGGCACTCGGCATTTTTAATTAAT
GTACCGTTTGCGATAATAGCAGTTGTAGCAGGTTTATTTTTATTACCAGAGTCTAAGTTA
TCAAAAGAAAAGTCTCACTCGTGGGATATTCCTTCTACAATTTTATCAATTGCAGGCATG
ATTGGACTGGTATGGAGTATCAAAGAATTTTCAAAAGAAGGACTAGCAGATATTATTCCA
TGGGTTGTAATAGTATTAGCAATTACCATGATAGTGATATTTGTTAAACGTAATTTATCA
AGTTCTGATCCAATGTTAGACGTAAGACTTTTTAAAAAGAGATCATTTTCAGCTGGTACA
ATTGCTGCATTTATGACAATGTTTGCAATGGCATCTGTTTTGTTATTAGCTTCACAATGG
TTACAGGTTGTGGAAGAACTTTCTCCTTTTAAAGCTGGCTTATACCTATTACCTATGGCA
ATAGGAGATATGGTGTTTGCACCAATTGCACCCGGATTAGCGGCGCGATTTGGACCGAAA
ATAGTGTTACCTTCCGGAATTGGAATTGCAGCCATTGGCATGTTTATTATGTATTTCTTT
GGTCATCCATTATCATATTCTACAATGGCTTTAGCATTAATTTTAGTTGGAGCTGGTATG
GCTTCACTAGCAGTTGCATCTGCTCTAATAATGTTAGAAACACCTACATCAAAAGCAGGT
AATGCAGCTGCTGTTGAAGAGTCTATGTATGACCTTGGAAATGTTTTTGGTGTAGCAGTA
CTTGGTAGCCTATCTTCTATGCTTTATCGTGTATTTTTAGATATTTCATCTTTTTCATCA
AAAGGTATAGTTGGAGATTTAGCTCATGTAGCTGAAGAATCTGTAGTGGGCGCTGTCGAA
GTAGCTAAAGCTACGGGGATAAAACAGCTTGCAAACGAGGCTGTAACATCATTTAATGAT
GCTTTTGTAGCAACTGCTTTAGTAGGTGGGATTATCATGATTATCATTTCAATAGTTGTC
TATTTGTTAATTCCCAAATCACTTGATATAACTAAACAAAAATAG

# Drug_Target_2_General_Function:
Transcription

# Drug_Target_2_General_References:
11717268	Grkovic S, Brown MH, Schumacher MA, Brennan RG, Skurray RA: The staphylococcal QacR multidrug regulator binds a correctly spaced operator as a pair of dimers. J Bacteriol. 2001 Dec;183(24):7102-9.
11739955	Schumacher MA, Miller MC, Grkovic S, Brown MH, Skurray RA, Brennan RG: Structural mechanisms of QacR induction and multidrug recognition. Science. 2001 Dec 7;294(5549):2158-63.
11867549	Schumacher MA, Miller MC, Grkovic S, Brown MH, Skurray RA, Brennan RG: Structural basis for cooperative DNA binding by two dimers of the multidrug-binding protein QacR. EMBO J. 2002 Mar 1;21(5):1210-8.
12648720	Schumacher MA, Brennan RG: Deciphering the molecular basis of multidrug recognition: crystal structures of the Staphylococcus aureus multidrug binding transcription regulator QacR. Res Microbiol. 2003 Mar;154(2):69-77.
2089219	Rouch DA, Cram DS, DiBerardino D, Littlejohn TG, Skurray RA: Efflux-mediated antiseptic resistance gene qacA from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteins. Mol Microbiol. 1990 Dec;4(12):2051-62.
9660841	Grkovic S, Brown MH, Roberts NJ, Paulsen IT, Skurray RA: QacR is a repressor protein that regulates expression of the Staphylococcus aureus multidrug efflux pump QacA. J Biol Chem. 1998 Jul 17;273(29):18665-73.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6461

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
22174.2

# Drug_Target_2_Name:
HTH-type transcriptional regulator qacR

# Drug_Target_2_Number_of_Residues:
188

# Drug_Target_2_PDB_ID:
1QVU

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00440	TetR_N
PF08360	TetR_C_5

# Drug_Target_2_Protein_Sequence:
>HTH-type transcriptional regulator qacR
MNLKDKILGVAKELFIKNGYNATTTGEIVKLSESSKGNLYYHFKTKENLFLEILNIEESK
WQEQWKKEQIKCKTNREKFYLYNELSLTTEYYYPLQNAIIEFYTEYYKTNSINEKMNKLE
NKYIDAYHVIFKEGNLNGEWCINDVNAVSKIAANAVNGIVTFTHEQNINERIKLMNKFSQ
IFLNGLSK

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Transcriptional repressor of qacA. Binds to IR1, an unusually long 28 bp operator, which is located downstream from the qacA promoter and overlaps its transcription start site. QacR is induced from its IR1 site by binding to one of many structurally dissimilar cationic lipophilic compounds, which are also substrates of qacA

# Drug_Target_2_SwissProt_ID:
P0A0N4

# Drug_Target_2_SwissProt_Name:
QACR_STAAU

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
8.55

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03808
